BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16870458)

  • 1. The key role of apoptosis in the pathogenesis and treatment of pulmonary hypertension.
    Gurbanov E; Shiliang X
    Eur J Cardiothorac Surg; 2006 Sep; 30(3):499-507. PubMed ID: 16870458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rho-kinase as a potential therapeutic target for the treatment of pulmonary hypertension.
    Xing XQ; Gan Y; Wu SJ; Chen P; Zhou R; Xiang XD
    Drug News Perspect; 2006 Nov; 19(9):517-22. PubMed ID: 17220956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells.
    Nishimura T; Vaszar LT; Faul JL; Zhao G; Berry GJ; Shi L; Qiu D; Benson G; Pearl RG; Kao PN
    Circulation; 2003 Sep; 108(13):1640-5. PubMed ID: 12963647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current insights on the pathogenesis of pulmonary arterial hypertension.
    Perros F; Dorfmüller P; Humbert M
    Semin Respir Crit Care Med; 2005 Aug; 26(4):355-64. PubMed ID: 16121311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging therapies for the treatment of pulmonary hypertension.
    Stenmark KR; Rabinovitch M
    Pediatr Crit Care Med; 2010 Mar; 11(2 Suppl):S85-90. PubMed ID: 20216170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic targets in pulmonary arterial hypertension.
    Rhodes CJ; Davidson A; Gibbs JS; Wharton J; Wilkins MR
    Pharmacol Ther; 2009 Jan; 121(1):69-88. PubMed ID: 19010350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins may ameliorate pulmonary hypertension via RhoA/Rho-kinase signaling pathway.
    Xing XQ; Gan Y; Wu SJ; Chen P; Zhou R; Xiang XD
    Med Hypotheses; 2007; 68(5):1108-13. PubMed ID: 17097823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary arterial hypertension: new insights and new hope.
    Martin KB; Klinger JR; Rounds SI
    Respirology; 2006 Jan; 11(1):6-17. PubMed ID: 16423196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins suppress MMP2 secretion via inactivation of RhoA/ROCK pathway in pulmonary vascular smooth muscles cells.
    Li M; Li Z; Sun X
    Eur J Pharmacol; 2008 Sep; 591(1-3):219-23. PubMed ID: 18619957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis and vascular wall remodeling in hypertension.
    Hamet P; deBlois D; Dam TV; Richard L; Teiger E; Tea BS; Orlov SN; Tremblay J
    Can J Physiol Pharmacol; 1996 Jul; 74(7):850-61. PubMed ID: 8946072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Update in basic research in the therapy of pulmonary arterial hypertension].
    Schermuly R; Grimminger F
    Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S170-2. PubMed ID: 18814088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel strategy for treatment of pulmonary arterial hypertension: enhancement of apoptosis.
    Huang JB; Liu YL; Sun PW; Lv XD; Bo K; Fan XM
    Lung; 2010 Jun; 188(3):179-89. PubMed ID: 20213196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rho kinase-mediated vasoconstriction in rat models of pulmonary hypertension.
    Oka M; Homma N; McMurtry IF
    Methods Enzymol; 2008; 439():191-204. PubMed ID: 18374166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined tyrosine and serine/threonine kinase inhibition by sorafenib prevents progression of experimental pulmonary hypertension and myocardial remodeling.
    Klein M; Schermuly RT; Ellinghaus P; Milting H; Riedl B; Nikolova S; Pullamsetti SS; Weissmann N; Dony E; Savai R; Ghofrani HA; Grimminger F; Busch AE; Schäfer S
    Circulation; 2008 Nov; 118(20):2081-90. PubMed ID: 18955668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
    Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
    Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of flow-induced pulmonary arterial vasculopathy after flow correction in piglets.
    Mercier O; Sage E; de Perrot M; Tu L; Marcos E; Decante B; Baudet B; Hervé P; Dartevelle P; Eddahibi S; Fadel E
    J Thorac Cardiovasc Surg; 2009 Jun; 137(6):1538-46. PubMed ID: 19464477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Rho-kinase and its inhibitors in pulmonary hypertension.
    Duong-Quy S; Bei Y; Liu Z; Dinh-Xuan AT
    Pharmacol Ther; 2013 Mar; 137(3):352-64. PubMed ID: 23261521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Novel concepts in the pathobiology of pulmonary arterial hypertension].
    Rosenkranz S
    Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S167-9. PubMed ID: 18814087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Update: Preclinical developments for the treatment of pulmonary arterial hypertension].
    Janssen W; Ghofrani HA; Weissmann N; Grimminger F; Schermuly RT
    Dtsch Med Wochenschr; 2009 Aug; 134 Suppl 5():S157-9. PubMed ID: 19718604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin elicits dilation of isolated porcine retinal arterioles: role of nitric oxide and mevalonate-rho kinase pathways.
    Nagaoka T; Hein TW; Yoshida A; Kuo L
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):825-32. PubMed ID: 17251484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.